1887
Preview this article:
Zoom in
Zoomout

Gas gangrene: an open and closed case, Page 1 of 1

| /docserver/preview/fulltext/micro/151/9/2821-1.gif

There is no abstract available for this article.
Use the preview function to the left.

Loading

Article metrics loading...

/content/journal/micro/10.1099/mic.0.28248-0
2005-09-01
2019-10-23
Loading full text...

Full text loading...

/deliver/fulltext/micro/151/9/mic1512821.html?itemId=/content/journal/micro/10.1099/mic.0.28248-0&mimeType=html&fmt=ahah

References

  1. Alape-Giron, A., Flores-Diaz, M., Guillouard, I. & 8 other authors ( 2000; ). Identification of residues critical for toxicity in Clostridium perfringens phospholipase C, the key toxin in gas gangrene. Eur J Biochem 267, 5191–5197.[CrossRef]
    [Google Scholar]
  2. Awad, M. M., Bryant, A. E., Stevens, D. L. & Rood, J. I. ( 1995; ). Virulence studies on chromosomal alpha-toxin and theta-toxin mutants constructed by allelic exchange provide genetic evidence for the essential role of alpha-toxin in Clostridium perfringens-mediated gas-gangrene. Mol Microbiol 15, 191–202.[CrossRef]
    [Google Scholar]
  3. Barker, A. P., Vasil, A. I., Filloux, A., Ball, G., Wilderman, P. J. & Vasil, M. L. ( 2004; ). A novel extracellular phospholipase C of Pseudomonas aeruginosa is required for phospholipid chemotaxis. Mol Microbiol 53, 1089–1098.[CrossRef]
    [Google Scholar]
  4. Basak, A. K., Stuart, D. I., Nikura, T., Bishop, D. H. L., Kelly, D. C., Fearn, A. & Titball, R. W. ( 1994; ). Purification, crystallization and preliminary X-ray diffraction studies of alpha-toxin of Clostridium perfringens. J Mol Biol 244, 648–650.[CrossRef]
    [Google Scholar]
  5. Bowman, S. ( 1998; ). Iraqi Chemical and Biological Weapons (CBW) Capabilities, pp. 1–5. Washington, DC: Congressional Research Service.
  6. Boyd, N. A., Thomson, R. O. & Walker, P. D. ( 1972; ). The prevention of experimental Clostridium novyi and Cl. perfringens gas gangrene in high-velocity missile wounds by active immunisation. J Med Microbiol 5, 467–472.[CrossRef]
    [Google Scholar]
  7. Bramley, A. J., Patel, A. H., O'Reilly, M., Foster, R. & Foster, T. J. ( 1989; ). Roles of alpha-toxin and beta-toxin in virulence of Staphylococcus aureus for the mouse mammary gland. Infect Immun 57, 2489–2494.
    [Google Scholar]
  8. Bryant, A. E., Chen, R. Y. Z., Nagata, Y., Wang, Y., Lee, C. H., Finegold, S., Guth, P. H. & Stevens, D. L. ( 2000a; ). Clostridial gas gangrene. I. Cellular and molecular mechanisms of microvascular dysfunction induced by exotoxins of Clostridium perfringens. J Infect Dis 182, 799–807.[CrossRef]
    [Google Scholar]
  9. Bryant, A. E., Chen, R. Y. Z., Nagata, Y., Wang, Y., Lee, C. H., Finegold, S., Guth, P. H. & Stevens, D. L. ( 2000b; ). Clostridial gas gangrene. II. Phospholipase C-induced activation of platelet gpIIbIIIa mediates vascular occlusion and myonecrosis in Clostridium perfringens gas gangrene. J Infect Dis 182, 808–815.[CrossRef]
    [Google Scholar]
  10. Clark, G. C., Briggs, D., Karasawa, T. & 10 other authors ( 2003; ). Clostridium absonum α-toxin – new insights into clostridial phospholipase C substrate binding and specificity. J Mol Biol 333, 759–769.[CrossRef]
    [Google Scholar]
  11. Cordesman, A. H. ( 1998; ). UNSCOM Main Achievements: United Nations Special Commission (UNSCOM), pp. 67–71. New York: United Nations.
  12. Cygan, Z. ( 1997; ). Properties, mechanisms of action and pathogenic role of alpha-toxin C. perfringens – a review. Med Weter 53, 73–76.
    [Google Scholar]
  13. Darwin, A. J. & Miller, V. L. ( 1999; ). Identification of Yersinia enterocolitica genes affecting survival in an animal host using signature-tagged transposon mutagenesis. Mol Microbiol 32, 51–62.[CrossRef]
    [Google Scholar]
  14. Eaton, J. T., Naylor, C. E., Howells, A. M., Moss, D. S., Titball, R. W. & Basak, A. K. ( 2002; ). Crystal structure of the C. perfringens alpha-toxin with the active site closed by a flexible loop region. J Mol Biol 319, 275–281.[CrossRef]
    [Google Scholar]
  15. Evans, D. G. ( 1945; ). The in-vitro production of alpha-toxin, theta-haemolysin and hyaluronidase by strains of Cl. welchii type A, and the relationship of in-vitro properties to virulence for guinea-pigs. J Pathol Bacteriol 57, 77–85.
    [Google Scholar]
  16. Flores-Diaz, M., Alape-Giron, A., Titball, R. W. & 7 other authors ( 1998; ). UDP-glucose deficiency causes hypersensitivity to the cytotoxic effect of Clostridium perfringens phospholipase C. J Biol Chem 273, 24433–24438.[CrossRef]
    [Google Scholar]
  17. Fujii, Y. & Sakurai, J. ( 1989; ). Contraction of the rat isolated aorta caused by Clostridium perfringens alpha toxin (phospholipase-C) – evidence for the involvement of arachidonic acid metabolism. Br J Pharmacol 97, 119–124.[CrossRef]
    [Google Scholar]
  18. Fujii, Y., Shirotani, M. & Sakurai, J. ( 1986; ). Effect of Clostridium perfringens alpha-toxin on rabbit platelets. Jpn J Med Sci Biol 39, 244–245.
    [Google Scholar]
  19. Ginter, A., Williamson, E. D., Dessy, F., Coppe, P., Bullifent, H., Howells, A. & Titball, R. W. ( 1996; ). Molecular variation between the alpha-toxins from the type strain (NCTC 8237) and clinical isolates of Clostridium perfringens associated with disease in man and animals. Microbiology 142, 191–198.[CrossRef]
    [Google Scholar]
  20. Granström, M., Erickson, A., Strandvik, B., Wretlind, B., Pavlovskis, O. R., Berka, R. & Vasil, M. ( 1984; ). Relationship between antibody response to Pseudomonas aeruginosa exoproteins and colonisation/infection in patients with cystic fibrosis. Acta Paediatr Scand 73, 772–777.[CrossRef]
    [Google Scholar]
  21. Grave, K., Kaldhusdal, M. C., Kruse, H., Harr, L. M. & Flatlandsmo, K. ( 2004; ). What has happened in Norway after the ban of avoparcin? Consumption of antimicrobials by poultry. Prev Vet Med 62, 59–72.[CrossRef]
    [Google Scholar]
  22. Guillouard, I., Garnier, T. & Cole, S. T. ( 1996; ). Use of site-directed mutagenesis to probe structure-function relationships of alpha-toxin from Clostridium perfringens. Infect Immun 64, 2440–2444.
    [Google Scholar]
  23. Gustafson, C. & Tagesson, C. ( 1990; ). Phospholipase-C from Clostridium perfringens stimulates phospholipase-A2-mediated arachidonic acid release in cultured intestinal epithelial cells (Int-407). Scand J Gastroenterol 25, 363–371.
    [Google Scholar]
  24. Heier, B. T., Lovland, A., Soleim, K. B., Kaldhusdal, M. & Jarp, J. ( 2001; ). A field study of naturally occurring specific antibodies against Clostridium perfringens alpha toxin in Norwegian broiler flocks. Avian Dis 45, 724–732.[CrossRef]
    [Google Scholar]
  25. Hinnebusch, B. J., Rudolph, A. E., Cherepanov, P., Dixon, J. E., Schwan, T. G. & Forsberg, A. ( 2002; ). Role of Yersinia murine toxin in survival of Yersinia pestis in the midgut of the flea vector. Science 296, 733–735.[CrossRef]
    [Google Scholar]
  26. Hodgson, A. L., Krywult, J., Corner, L. A., Rothel, J. S. & Radford, A. J. ( 1992; ). Rational attenuation of Corynebacterium pseudotuberculosis: potential cheesy gland vaccine and live delivery vehicle. Infect Immun 60, 2900–2905.
    [Google Scholar]
  27. Holm, B. A., Keicher, L., Liu, M., Sokolowski, J. & Enhorning, G. ( 1991; ). Inhibition of pulmonary surfactant function by phospholipases. J Appl Physiol 71, 317–321.
    [Google Scholar]
  28. Justin, N., Walker, N., Bullifent, H. L. & 8 other authors ( 2002; ). The first strain of Clostridium perfringens isolated from an avian source has an alpha-toxin with divergent structural and kinetic properties. Biochemistry 41, 6253–6262.[CrossRef]
    [Google Scholar]
  29. Kameyama, S., Sato, H. & Murata, R. ( 1975; ). The role of α-toxin of Clostridium perfringens in experimental gas gangrene in guinea pigs. Jpn J Med Sci Biol 25, 200.
    [Google Scholar]
  30. Karlyshev, A. V., Oyston, P. C., Williams, K., Clark, G. C., Titball, R. W., Winzeler, E. A. & Wren, B. W. ( 2001; ). Application of high-density array-based signature-tagged mutagenesis to discover novel yersinia virulence-associated genes. Infect Immun 69, 7810–7819.[CrossRef]
    [Google Scholar]
  31. König, B., Vasil, M. L. & König, W. ( 1997; ). Role of hemolytic and nonhemolytic phospholipase C from Pseudomonas aeruginosa for inflammatory mediator release from human granulocytes. Int Arch Allergy Immunol 112, 115–124.[CrossRef]
    [Google Scholar]
  32. Krug, E. L. & Kent, C. ( 1984; ). Phospholipase C from Clostridium perfringens: preparation and characterisation of homogenous enzyme. Arch Biochem Biophys 231, 400–410.[CrossRef]
    [Google Scholar]
  33. Langton, S. R. & Cesareo, S. D. ( 1992; ). Helicobacter pylori associated phospholipase A2 activity: a factor in peptic ulcer production. J Clin Pathol 45, 221–224.[CrossRef]
    [Google Scholar]
  34. Lovland, A., Kaldhusdal, M., Redhead, K., Skjerve, E. & Lillehaug, A. ( 2004; ). Maternal vaccination against subclinical necrotic enteritis in broilers. Avian Pathol 33, 83–92.
    [Google Scholar]
  35. MacFarlane, M. G. ( 1955; ). On the Biochemical Mechanisms of Action of Gas Gangrene Toxins. Cambridge: Cambridge University Press.
  36. MacLennan, J. D. ( 1962; ). The histotoxic clostridial infections of man. Bacteriol Rev 26, 177–276.
    [Google Scholar]
  37. MacLennan, J. D. & MacFarlane, M. G. ( 1944; ). The treatment of gas gangrene. Br Med J II, 683.
    [Google Scholar]
  38. McNamara, P. J., Bradley, G. A. & Songer, J. G. ( 1994; ). Targeted mutagenesis of the phospholipase D gene results in decreased virulence of Corynebacterium pseudotuberculosis. Mol Microbiol 12, 921–930.[CrossRef]
    [Google Scholar]
  39. McNee, J. W. & Dunn, J. S. ( 1917; ). The method of spread of gas gangrene into living muscle. Br Med J 1, 727–729.
    [Google Scholar]
  40. Nagahama, M., Nakayama, T., Kobayashi, K. & Sakurai, J. ( 1995a; ). Site-directed mutagenesis studies on the zinc-binding domain of Clostridium perfringens alpha toxin. Jpn J Med Sci Biol 48, 265–266.
    [Google Scholar]
  41. Nagahama, M., Ochi, S., Kobayashi, K. & Sakurai, J. ( 1995b; ). The relationship between histidine residues and various biological activities of Clostridium perfringens alpha-toxin. Abstr Pap Am Chem Soc 209, 75-AGFD.
    [Google Scholar]
  42. Nagahama, M., Nakayama, T., Michiue, K. & Sakurai, J. ( 1997; ). Site-specific mutagenesis of Clostridium perfringens alpha-toxin: replacement of Asp-56, Asp-130, or Glu-152 causes loss of enzymatic and hemolytic activities. Infect Immun 65, 3489–3492.
    [Google Scholar]
  43. Naylor, C. E., Eaton, J. T., Howells, A., Justin, N., Moss, D. S., Titball, R. W. & Basak, A. K. ( 1998; ). Structure of the key toxin in gas gangrene. Nat Struct Biol 5, 738–746.[CrossRef]
    [Google Scholar]
  44. Naylor, C. E., Jepson, M., Crane, D. T., Titball, R. W., Miller, J., Basak, A. K. & Bolgiano, B. ( 1999; ). Characterisation of the calcium-binding C-terminal domain of Clostridium perfringens alpha-toxin. J Mol Biol 294, 757–770.[CrossRef]
    [Google Scholar]
  45. Ohsaka, A., Tsuchiya, M., Oshio, C., Miyaira, M., Suzuki, K. & Yamkawa, Y. ( 1978; ). Aggregation of platelets in the micro-circulation of the rat induced by the alpha-toxin (phospholipase C) of Clostridium perfringens. Toxicon 16, 333–341.[CrossRef]
    [Google Scholar]
  46. Ottlecz, A., Romero, J. J., Hazell, S. L., Graham, D. Y. & Lichtenberger, L. M. ( 1993; ). Phospholipase activity of Helicobacter pylori and its inhibition by bismuth salts. Dig Dis Sci 38, 2071–2080.[CrossRef]
    [Google Scholar]
  47. Rahme, L. G., Stevens, E. J., Wolfort, S. F., Shao, J., Tompkins, R. G. & Ausubel, F. M. ( 1995; ). Common virulence factors for bacterial pathogenicity in plants and animals. Science 268, 1899–1902.[CrossRef]
    [Google Scholar]
  48. Raynaud, C., Guilhot, C., Rauzier, J., Bordat, Y., Pelicic, V., Manganelli, R., Smith, I., Gicquel, B. & Jackson, M. ( 2002; ). Phospholipases C are involved in the virulence of Mycobacterium tuberculosis. Mol Microbiol 45, 203–217.[CrossRef]
    [Google Scholar]
  49. Saiman, L., Cacalano, G., Gruenert, D. & Prince, A. ( 1992; ). Comparison of adherence of Pseudomonas aeruginosa to respiratory epithelial cells from cystic fibrosis patients and healthy subjects. Infect Immun 60, 2808–2814.
    [Google Scholar]
  50. Samuelsson, B. ( 1983; ). Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science 220, 568–575.[CrossRef]
    [Google Scholar]
  51. Sato, H. & Frank, D. W. ( 2004; ). ExoU is a potent intracellular phospholipase. Mol Microbiol 53, 1279–1290.[CrossRef]
    [Google Scholar]
  52. Sheedy, S. A., Ingham, A. B., Rood, J. I. & Moore, R. J. ( 2004; ). Highly conserved alpha-toxin sequences of avian isolates of Clostridium perfringens. J Clin Microbiol 42, 1345–1347.[CrossRef]
    [Google Scholar]
  53. Shortridge, V. D., Lazdunski, A. & Vasil, M. L. ( 1992; ). Osmoprotectants and phosphate regulate expression of phospholipase C in Pseudomonas aeruginosa. Mol Microbiol 6, 863–871.[CrossRef]
    [Google Scholar]
  54. Smith, G. A., Marquis, H., Jones, S., Johnston, N. C., Portnoy, D. A. & Goldfine, H. ( 1995; ). The two distinct phospholipases C of Listeria monocytogenes have overlapping roles in escape from a vacuole and cell-to-cell spread. Infect Immun 63, 4231–4237.
    [Google Scholar]
  55. Songer, J. G. ( 2002; ). Gas gangrene and myonecrosis. In Molecular Genetics, Classification, Pathology and Ecology of the Genus Clostridium, pp. 53–62. Edited by C. Duchesnes & J. Mainil. Liège: Presses de la Faculté de Médecine Vétérinaire de l'Université de Liège.
  56. Stevens, D. L., Titball, R. W., Jepson, M., Bayer, C., Schroer, S. & Bryant, A. E. ( 2004; ). Immunization with C-domain of alpha-toxin prevents lethal infection, localizes tissue injury and promotes host response to challenge with viable Clostridium perfringens. J Infect Dis 190, 767–773.[CrossRef]
    [Google Scholar]
  57. Sugahara, T., Takahashi, T., Yamaya, S. & Ohsaka, A. ( 1977; ). In vitro aggregation of platelets induced by alpha-toxin (phospholipase C) of Clostridium perfringens. Jpn J Med Sci Biol 29, 255–263.
    [Google Scholar]
  58. Titball, R. W. ( 1999; ). Membrane-damaging and cytotoxic phospholipases. In The Comprehensive Sourcebook of Bacterial Protein Toxins, pp. 310–329. Edited by J. E. Alouf & J. H. Freer. London: Academic Press.
  59. Titball, R. W. & Rood, J. I. ( 1999; ). Bacterial phospholipases. In Bacterial Protein Toxins, pp. 529–556. Edited by K. Aktories & I. Just. Berlin, Heidelberg, New York: Springer.
  60. Titball, R. W. & Rubidge, T. ( 1990; ). The role of histidine residues in the alpha toxin of Clostridium perfringens. FEMS Microbiol Lett 68, 261–265.
    [Google Scholar]
  61. Titball, R. W., Hunter, S. E. C., Martin, K. L., Morris, B. C., Shuttleworth, A. D., Rubidge, T., Anderson, D. W. & Kelly, D. C. ( 1989; ). Molecular cloning and nucleotide sequence of the alpha-toxin (phospholipase-C) of Clostridium perfringens. Infect Immun 57, 367–376.
    [Google Scholar]
  62. Titball, R. W., Leslie, D. L., Harvey, S. & Kelly, D. ( 1991; ). Hemolytic and sphingomyelinase activities of Clostridium perfringens alpha-toxin are dependent on a domain homologous to that of an enzyme from the human arachidonic acid pathway. Infect Immun 59, 1872–1874.
    [Google Scholar]
  63. Titball, R. W., Fearn, A. M. & Williamson, E. D. ( 1993; ). Biochemical and immunological properties of the C-terminal domain of the alpha-toxin of Clostridium perfringens. FEMS Microbiol Lett 110, 45–50.[CrossRef]
    [Google Scholar]
  64. Tsutsui, K., Minami, J., Matsushita, O., Katayama, S., Taniguchi, Y., Nakamura, S., Nishioka, M. & Okabe, A. ( 1995; ). Phylogenetic analysis of phospholipase-C genes from Clostridium perfringens Type-A to Type-E and Clostridium novyi. J Bacteriol 177, 7164–7170.
    [Google Scholar]
  65. Van Immerseel, F., De Buck, J., Pasmans, F., Huyghebaert, G., Haesebrouck, F. & Ducatelle, R. ( 2004; ). Clostridium perfringens in poultry: an emerging threat for animal and public health. Avian Pathol 33, 537–549.[CrossRef]
    [Google Scholar]
  66. Walker, N., Holley, J., Naylor, C. E. & 10 other authors ( 2000; ). Identification of residues in the carboxy-terminal domain of Clostridium perfringens alpha-toxin (phospholipase C) which are required for its biological activities. Arch Biochem Biophys 384, 24–30.[CrossRef]
    [Google Scholar]
  67. Wierup, M. ( 2001; ). The Swedish experience of the 1986 year ban of antimicrobial growth promoters, with special reference to animal health, disease prevention, productivity, and usage of antimicrobials. Microb Drug Resist 7, 183–190.[CrossRef]
    [Google Scholar]
  68. Williamson, E. D. & Titball, R. W. ( 1993; ). A genetically engineered vaccine against the alpha-toxin of Clostridium perfringens protects mice against experimental gas-gangrene. Vaccine 11, 1253–1258.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/micro/10.1099/mic.0.28248-0
Loading
/content/journal/micro/10.1099/mic.0.28248-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error